IP Library › Granted Patent US 9,700,440
Granted Patent B2
US 9,700,440 · App. 13/937,097 · Granted Jul 11, 2017

Implant and method for manufacturing same

Inventors: Ullrich Bayer (Admannshagen-Bargeshagen, DE); Bodo Gerold (Zellingen, DE)
Assignee: BIOTRONIK VI PATENT AG
A61F2/82A61L31/022A61L31/084A61L31/148C23C8/20C23C8/22C23C8/24C23C8/26C23C8/30C23C8/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,700,440
App. No.
13/937,097
Granted
Jul 11, 2017
Kind
B2
Abstract

The present invention relates to a method for manufacturing an implant, in particular an intraluminal endoprosthesis, having a body containing metallic material, preferably iron. For controlling the degradation of the implant the method includes the following steps: (a) providing a first part of the implant body; and (b) performing heat treatment which alters the carbon content and/or the boron content and/or the nitrogen content in the structure of a near-surface boundary layer in the first part of the implant body in such a way that strain on the lattice or a lattice transformation, optionally following a subsequent mechanical load, is achieved in the near-surface boundary layer. Such an implant is also described.

Claims (28)

1. A method for manufacturing a biodegradable implant, wherein the implant is an endovascular stent, the method comprising the following steps:

a) providing a first part of an endovascular stent body, wherein the body comprises a metallic material, optionally iron; and

b) performing a heat treatment on the body which alters a content of boron, or decreases a content of carbon in a structure of a near-surface boundary layer in the first part of the body in such a way that strain on a lattice or a lattice transformation, optionally following a subsequent mechanical load, is achieved in the near-surface boundary layer.

2. The method according to claim 1 , wherein after step b) a second part of the endovascular stent body is provided, after which the second part is positioned over the first part in such a way that the second part adjoins the first part, at least in a partial region of the near-surface boundary layer, and a system composed of the first and second parts is then subjected to heat treatment according to step b).

3. The method according to claim 1 , wherein during the heat treatment according to step b) the boron content in the structure of the near-surface boundary layer is increased by boronization, the boundary layer optionally having a maximum thickness of approximately 300 μm.

4. The method according to claim 3 , wherein the average concentration of boron in the near-surface boundary layer after the boronization is approximately 1% by weight to approximately 20% by weight.

5. The method according to claim 1 , wherein during the heat treatment according to step b) the content of carbon in the structure of the near-surface boundary layer is reduced by decarburization, the boundary layer optionally having a maximum thickness of approximately 50 μm.

6. The method according to claim 5 , wherein the average concentration of carbon in the near-surface boundary layer after the decarburization is approximately 0.1% by weight to approximately 0.3% by weight.

7. The method according to claim 5 , wherein if the heat treatment is to decrease the content of carbon the part of the implant body treated by decarburization is quickly cooled.

8. The method according to claim 1 , wherein after the heat treatment according to step b), tribochemical treatment of the body is carried out on at least a portion of the surface thereof, and/or coating of the body with a pharmaceutically active substance is carried out on at least a portion of the surface thereof.

9. The method according to claim 1 , wherein the body comprises manganese.

10. The method according to claim 1 , wherein the treatment configures the endovascular stent to crack at the near surface area upon application of a mechanical load on the endovascular stent to facilitate degradation.

11. The method according to claim 1 , wherein the body is dilatable, further wherein the treatment configures the dilatable body to crack at the near surface area upon application of a mechanical load after dilation to facilitate degradation.

12. A method for manufacturing a biodegradable implant, the method comprising the following steps:

a) providing a first part of an implant body, wherein the body comprises a metallic material, optionally iron; and

b) performing a heat treatment on the body which alters a content of boron, or decreases a content of carbon, in a structure of a near-surface boundary layer in the first part of the body in such a way that strain on a lattice or a lattice transformation, optionally following a subsequent mechanical load, is achieved in the near-surface boundary layer, wherein during the heat treatment the boron content in the structure of the near surface boundary layer is increased by boronization, the boundary layer optionally having a maximum thickness of approximately 300 μm, further wherein the average concentration of boron in the near-surface boundary layer after the boronization is approximately 1% by weight to approximately 20% by weight.

13. The method according to claim 12 , wherein the average concentration of boron in the near-surface boundary layer after the boronization is approximately 7% by weight to approximately 10% by weight.

14. The method according to claim 12 , wherein the implant is an endovascular stent.

15. The method according to claim 12 , wherein the implant is selected from the group consisting of a bone screw, a bone plate, a bone pin, an intramedullary pin, a spiral bundle nail, a Kirschner wire, a wire for septal occluders, a surgical suture, an intestinal clamp, a vessel clip, and an electrode anchoring element.

16. The method according to claim 12 , wherein the treatment configures the implant to crack at the near surface area upon application of a mechanical load on the implant to facilitate degradation.

17. A method for manufacturing a biodegradable implant, wherein the implant is an endovascular stent, the method comprising the following steps:

a) providing a first part of an endovascular stent body, wherein the body comprises a metallic material, optionally iron; and

b) performing a heat treatment on the body which alters a content of boron or nitrogen in a structure of a near-surface boundary layer in the first part of the body in such a way that strain on a lattice or a lattice transformation, optionally following a subsequent mechanical load, is achieved in the near-surface boundary layer.

18. The method according to claim 17 , wherein the body is dilatable.

19. The method according to claim 17 , wherein during the heat treatment according to step b) the nitrogen content in the structure of the near-surface boundary layer is increased by nitriding, or carbon and the nitrogen content in the structure of the near-surface boundary layer is increased by nitrocarburization, the boundary layer optionally having a maximum thickness of approximately 150 μm.

20. The method according to claim 19 , wherein the average concentration of nitrogen in the near-surface boundary layer after the nitriding is approximately 0.5% by weight to approximately 17% by weight, optionally approximately 5% by weight to approximately 12% by weight.

21. The method according to claim 17 , wherein the treatment configures the body to crack at the near surface area upon application of a mechanical load after dilation to facilitate degradation.

22. The method according to claim 17 , wherein during the heat treatment according to step b) the boron content in the structure of the near-surface boundary layer is increased by boronization, further wherein the average concentration of boron in the near-surface boundary layer after the boronization is approximately 1% by weight to approximately 20% by weight.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: BIOTRONIK VI PATENT AG
To: BIOTRONIK AG
Reel/Frame 045853/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2013
From: BAYER, ULLRICH; GEROLD, BODO, DR.
To: BIOTRONIK VI PATENT AG
Reel/Frame 030753/0891 →
Continuity (3)
Continuation 12836068 · Jul 14, 2010
Provisional Application 61246173 · Sep 28, 2009
Related Publication 20130304178A1 · Nov 14, 2013